Insider sale
INTRA-CELLULAR THERAPIES, INC.
$4.17M
31.75K shares
What this filing means
ALEXANDRIA VENTURE INVESTMENTS, LLC plans to sell 31.75K shares of INTRA-CELLULAR THERAPIES, INC. valued at approximately $4.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/18/2025ACC: 0001950047-25-002002
→
31.75K
Shares to sell
$4.17M
Approx. market value
20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Private Acquisition from Issuer/Affiliate
Cash
2/10/2021
20KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2021 | Private Acquisition from Issuer/Affiliate Cash | 20K | — |
| Total | 20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11.75K
Market value
$1.54M
3/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$2.63M
3/18/2025
Total
Units
31.75K
Value
$4.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2025 | 11.75K | $1.54M | — | Completed |
| Planned — Approximate Date | ||||
3/18/2025 | 20K | $2.63M | NASDAQ | Planned |
| Total | 31.75K | $4.17M | ||